Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


HIV meets its antibody match

Antibodies that neutralize many strains of HIV seem to work by interacting with the virus's sugary coating.


Dennis Burton and Ian Wilson at the Scripps Research Institute in La Jolla, California, led a team that obtained detailed crystal structures of two broadly neutralizing antibodies bound to mannose sugars, which are present in the coat of the virus. The structure of one of the antibodies, PGT 128 (pictured), shows that it penetrates the viral coating and binds to a short strand of an HIV envelope protein called gp120, as well as to two sugars that are conserved across many HIV strains. This explains why PGT 128 can neutralize more than 70% of strains.

The results suggest that the antibodies achieve their potency by crosslinking highly accessible sections of key proteins on the surface of HIV particles. The authors say that these regions could be targets for vaccines.

Science 10.1126/science.1213256 (2011)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

HIV meets its antibody match. Nature 478, 289 (2011).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing